WINT
Price:
$0.4299
Market Cap:
$3.86M
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF, an aerosolized KL4 surfactant, which is in Phase IIb clinical trial to treat respiratory distress syndrome in premature infants; Lyophilized KL4 surfactant, which is in Phase IIa clinical trial for the treatment of lung injury resulting from COVID-1...[Read more]
Industry
Biotechnology
IPO Date
1995-08-07
Stock Exchange
NASDAQ
Ticker
WINT
According to Windtree Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -76.34% compared to the average of -0.08 of the last 4 quarters.
The mean historical PE Ratio of Windtree Therapeutics, Inc. over the last ten years is -8.36. The current -0.02 PE Ratio has changed -76.08% with respect to the historical average. Over the past ten years (40 quarters), WINT's PE Ratio was at its highest in in the December 2017 quarter at 24.67. The PE Ratio was at its lowest in in the June 2019 quarter at -103.52.
Average
-8.36
Median
-4.03
Minimum
-40.34
Maximum
-0.14
Discovering the peaks and valleys of Windtree Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 367.44%
Maximum Annual PE Ratio = -0.14
Minimum Annual Increase = -83.12%
Minimum Annual PE Ratio = -40.34
Year | PE Ratio | Change |
---|---|---|
2023 | -0.14 | -12.69% |
2022 | -0.16 | -75.64% |
2021 | -0.64 | -78.99% |
2020 | -3.05 | -20.64% |
2019 | -3.84 | -80.49% |
2018 | -19.69 | 367.44% |
2017 | -4.21 | -11.18% |
2016 | -4.74 | -30.34% |
2015 | -6.81 | -83.12% |
2014 | -40.34 | -18.48% |
The current PE Ratio of Windtree Therapeutics, Inc. (WINT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.31
5-year avg
-1.57
10-year avg
-8.36
Windtree Therapeutics, Inc.’s PE Ratio is greater than NeuroBo Pharmaceuticals, Inc. (-0.87), greater than Palisade Bio, Inc. (-0.22), greater than Lixte Biotechnology Holdings, Inc. (-1.12), greater than Avenue Therapeutics, Inc. (-0.22), less than ContraFect Corporation (-0.00),
Company | PE Ratio | Market cap |
---|---|---|
-0.87 | $20.33M | |
-0.22 | $2.74M | |
-1.12 | $4.50M | |
-0.22 | $3.59M | |
-0.00 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Windtree Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Windtree Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Windtree Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Windtree Therapeutics, Inc. (WINT)?
What is the highest PE Ratio for Windtree Therapeutics, Inc. (WINT)?
What is the 3-year average PE Ratio for Windtree Therapeutics, Inc. (WINT)?
What is the 5-year average PE Ratio for Windtree Therapeutics, Inc. (WINT)?
How does the current PE Ratio for Windtree Therapeutics, Inc. (WINT) compare to its historical average?